Clinical analysis of emergency liver transplantation: The role of living donor liver transplantation

Clinical Transplantation

Volumn 26, Issue 6, 2012, Pages 833-841

  Kim, Say June ^a   Yoon, Yung Chul ^a   Yoo, Young Kyung ^a   Park, Jung Hyun ^a   Kim, Dong Goo ^a  

^a Daejeon St Mary's Hospital   (South Korea)

Author keywords

Acute liver failure; Deceased donor liver transplantation; Emergency liver transplantation; Living donor liver transplantation; Model for end stage liver disease

Indexed keywords

ADENINE NUCLEOTIDE DERIVATIVE; ALANINE AMINOTRANSFERASE; ANTITHROMBIN III; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATININE; CYCLOSPORIN; FRESH FROZEN PLASMA; HEPATITIS B ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PROSTAGLANDIN E1; STEROID; TACROLIMUS;

ABDOMINAL BLEEDING; ACINETOBACTER INFECTION; ACUTE GRAFT REJECTION; ACUTE LIVER FAILURE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANGIOGRAPHY; ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; ARTICLE; ASCITES; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPERGILLOSIS; BILE LEAKAGE; BILIRUBIN BLOOD LEVEL; CADAVER DONOR; CANDIDIASIS; CAUSE OF DEATH; CHRONIC LIVER DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DOPPLER FLOWMETRY; DUODENUM ULCER; EMERGENCY SURGERY; END STAGE LIVER DISEASE; ENTEROCOCCAL INFECTION; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HEPATITIS B; HOSPITAL ADMISSION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; INTUBATION; LENGTH OF STAY; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MELD SCORE; OPERATION DURATION; PLEURA EFFUSION; PNEUMONIA; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SCORING SYSTEM; SEPSIS; STAPHYLOCOCCUS INFECTION; SURGICAL INFECTION; SURGICAL MORTALITY; SURVIVAL; SURVIVAL TIME; SURVIVOR; THROMBOSIS; URINARY TRACT INFECTION; VASCULAR PATENCY; VEIN THROMBOSIS; WOUND COMPLICATION;

ADOLESCENT; ADULT; AGED; CADAVER; DISEASE PROGRESSION; EMERGENCY TREATMENT; END STAGE LIVER DISEASE; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HOSPITAL MORTALITY; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84870712143     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2012.01634.x     Document Type: Article

References (21)

1. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. Results of the first year of the new liver allocation plan. Liver Transpl 2004: 10: 7.
2. Wang VS, Saab S. Liver transplantation in the era of model for end-stage liver disease. Liver Int 2004: 24: 1.
3. Campsen J, Blei AT, Emond JC et al. Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study. Liver Transpl 2008: 14: 1273.
4. Liu CL, Fan ST, Lo CM, Yong BH, Fung AS, Wong J. Right-lobe live donor liver transplantation improves survival of patients with acute liver failure. Br J Surg 2002: 89: 317.
5. Marcos A, Ham JM, Fisher RA et al. Emergency adult to adult living donor liver transplantation for fulminant hepatic failure. Transplantation 2000: 69: 2202.
6. Park SJ, Lim YS, Hwang S et al. Emergency adult-to-adult living-donor liver transplantation for acute liver failure in a hepatitis B virus endemic area. Hepatology 2010: 51: 903.
7. Shi-Chun L, Meng-Long W, Ning L et al. Emergent right lobe adult-to-adult living-donor liver transplantation for high model for end-stage liver disease score severe hepatitis. Transpl Int 2010: 23: 23.
8. Uemoto S, Inomata Y, Sakurai T et al. Living donor liver transplantation for fulminant hepatic failure. Transplantation 2000: 70: 152.
9. Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet 2010: 376: 190.
10. Farmer DG, Anselmo DM, Ghobrial RM et al. Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period. Ann Surg 2003: 237: 666; discussion 75.
11. Rolando N, Philpott-Howard J, Williams R. Bacterial and fungal infection in acute liver failure. Semin Liver Dis 1996: 16: 389.
12. Rolando N, Harvey F, Brahm J et al. Prospective study of bacterial infection in acute liver failure: an analysis of fifty patients. Hepatology 1990: 11: 49.
13. Akyildiz M, Karasu Z, Arikan C et al. Impact of pretransplant MELD score on posttransplant outcome in living donor liver transplantation. Transplant Proc 2004: 36: 1442.
14. Hayashi PH, Forman L, Steinberg T et al. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients. Liver Transpl 2003: 9: 737.
15. Marubashi S, Dono K, Asaoka T et al. Risk factors for graft dysfunction after adult-to-adult living donor liver transplantation. Transplant Proc 2006: 38: 1407.
16. Habib S, Berk B, Chang CC et al. MELD and prediction of post-liver transplantation survival. Liver Transpl 2006: 12: 440.
17. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database. Liver Transpl 2004: 10: 886.
18. Thuluvath PJ, Guidinger MK, Fung JJ, Johnson LB, Rayhill SC, Pelletier SJ. Liver transplantation in the United States, 1999-2008. Am J Transplant 2010: 10: 1003.
19. Selzner M, Kashfi A, Cattral MS et al. Live donor liver transplantation in high MELD score recipients. Ann Surg 2010: 251: 153.
20. De Rave S, Tilanus HW, Van Der Linden J et al. The importance of orthotopic liver transplantation in acute hepatic failure. Transpl Int 2002: 15: 29.
21. Peleman RR, Gavaler JS, Van Thiel DH et al. Orthotopic liver transplantation for acute and subacute hepatic failure in adults. Hepatology 1987: 7: 484.